Innaxon Therapeutics seeks to grow through collaborations, partnerships and new ventures.
Where appropriate, we pursue key technology and product licensing/acquisition strategies to build our future value. By implementing this strategy, we will continue in its quest to become a leading provider of smart (bio-)pharmaceutical products, which modulate the master key of the innate immune system -Toll-like Receptor 4- to serve serious, unmet medical needs.
Product/technology development opportunities that are of interest to Innaxon fall into the following commercial areas:
- Therapeutic Vaccines and Adjuvants
- Infectious Diseases
- Immunotherapy of Cancer
If you have any questions about Innaxon Business Development activities, please contact:
Business Development and Alliances
St. Philips Central
Phone: +44 (0)1684 851 274